The US FDA has granted breakthrough therapy designation to Arrowhead Pharmaceuti...
After successfully completing two trials, SWIFT-1 and SWIFT-2, for its long-acti...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
Sildenafil citrate is under clinical development by XOMA Royalty and currently i...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
CMN-005 is under clinical development by CoImmune and currently in Phase II for ...
The atopic dermatitis market is facing increased growth, with a projected market...
A study suggests that children may face a higher risk of harm if their father is...
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD...
